O6.8. GLUTAMATERGIC DYSFUCTION AND TREATMENT RESPONSE IN MINIMALLY TREATED AND CHRONIC SCHIZOPHRENIA PATIENTS

BACKGROUND: Glutamatergic dysfunction as a result of NMDA receptor hypofunction has been implicated in antipsychotic treatment-resistant schizophrenia, however its nature in very early stages and chronic stages of the disease is still unknown. Data on glutamate and treatment response are currently l...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Schizophr Bull
Egile Nagusiak: Mouchlianitis, Elias, Vanes, Lucy, Barry, Erica, Patel, Krisna, Wong, Katie, Porfy, Lilla, Shergill, Sukhi
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Oxford University Press 2018
Gaiak:
Abstracts
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5887993/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/schbul/sby015.229
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak